Table 2 Global DALYs resulting from incident RR-TB in 2020 by country grouping

From: Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis

Region

RR-TB DALYs per 100,000

DALYs per RR-TB case

Total RR-TB DALYs (millions)

Percent of global RR-TB burden (%)

African Region

152.0 (111.4, 204.4)

23.0 (18.4, 27.3)

1.72 (1.26, 2.32)

24.8 (20.1, 31.0)

Region of the Americas

13.7 (9.0, 20.1)

13.9 (10.6, 17.2)

0.14 (0.09, 0.21)

2.0 (1.4, 2.8)

Eastern Mediterranean Region

83.6 (41.8, 138.2)

14.8 (10.5, 19.4)

0.63 (0.32, 1.04)

9.0 (5.2, 14.2)

European Region, excluding former Soviet Uniona

3.2 (2.4, 4.1)

11.7 (8.7, 14.7)

0.02 (0.01, 0.03)

0.3 (0.2, 0.4)

Former Soviet Union countriesa

290.7 (225.2, 369.1)

14.2 (11.1, 17.4)

0.87 (0.68, 1.11)

12.6 (10.5, 15.0)

South-East Asia Region

126.1 (99.9, 153.4)

19.6 (15.9, 23.3)

2.57 (2.04, 3.13)

37.2 (32.6, 41.9)

Western Pacific Region

50.5 (34.6, 71.1)

12.2 (8.8, 15.8)

0.97 (0.67, 1.37)

14.0 (11.2, 17.5)

High MDR/RR-TB burden

129.8 (101.0, 161.6)

17.0 (13.3, 20.3)

5.96 (4.63, 7.42)

85.9 (82.5, 88.4)

Global

88.8 (70.7, 109.2)

17.3 (13.8, 20.6)

6.93 (5.52, 8.53)

100 (100, 100)

  1. DALYs disability-adjusted life years, RR-TB rifampicin-resistant tuberculosis.
  2. Values in parentheses represent 95% uncertainty intervals.
  3. aFormer Soviet Union countries reported separately from the European Region, given their different epidemiology of tuberculosis drug resistance. High MDR/RR-TB countries include Angola, Azerbaijan, Bangladesh, Belarus, China, Democratic Republic of Congo, Indonesia, India, Kazakhstan, Kyrgyzstan, Moldova, Myanmar, Mongolia, Mozambique, Nigeria, Nepal, Pakistan, Peru, Philippines, Papua New Guinea, North Korea, Russia, Somalia, Tajikistan, Ukraine, Uzbekistan, Viet Nam, South Africa, Zambia, and Zimbabwe.
Back to article page